Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Class A Common Stock, par value $0.001 per share
- Total 13F shares
- 14,513,290
- Total 13F value
- $186,104,000
- Share change
- +14,513,290
- SEC-reported price per share
- $13.25
- Number of holders
- 21
- Value change
- +$186,104,000
- Number of buys
- 21
- Shares outstanding
- 72,325,000
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
21
Top holders
10
VERA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Ownership snapshot
Top reported holders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Abingworth LLP
Disclosed value leader
Emster Kurt von
Comparable rows
0/2
Latest evidence
17 May 2021
3/4/5
Highest disclosed value: $53,605,062
2 rows are not safely comparable across share classes.
Quick read
Emster Kurt von has the largest disclosed position value at $53.61M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Emster Kurt von's linked filing trail.
Disclosed position value
Top 2
Abingworth LLP
$53.28M
Emster Kurt von
$53.61M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Abingworth LLP |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$53,284,158
2,970,156 shares
mixed-class rows
|
— | 13 May 2021 |
| Emster Kurt von |
3/4/5
Director
|
—
mixed-class rows
|
$53,605,062
2,987,984 shares
mixed-class rows
|
— | 17 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
14,513,290
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q4 2025 Across Filers
Q4 2025 holders
214
Q2 2021 holders
21
Holder diff
-193
| Investor | Q4 2025 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend